The comparison exposes cracks in US healthcare, where the focus is more on treatment than prevention, says Rishi Wadhera.

Denmark OUT (Photo by MADS CLAUS RASMUSSEN/Ritzau Scanpix/AFP via Getty Images) · MADS CLAUS RASMUSSEN via Getty Images But the biggest reason Novo isn't overly concerned is because Medicare is ...

A new study finds that cardiovascular hospitalization rates are significantly higher in the United States compared to Denmark — another high-income country but with a distinctly different healthcare ...

It comes after US President Donald Trump spoke to both the Ukrainian and Russian leaders, and suggested negotiations to end ...

Billionaire adviser to Donald Trump, Elon Musk, is running the non-government body called Department of Government Efficiency ...

NYSE-listed shares of Novo Nordisk surged 4% on Wednesday morning after the Danish pharmaceutical giant posted better-than-expected fourth-quarter earnings. The company reported earnings of 6.34 ...

Novo Nordisk (NVO) CEO Lars Jørgensen isn't too worried about the upcoming Medicare price negotiations over blockbuster GLP-1 drugs, even though the company still stands with the industry against ...

COPENHAGEN (Reuters) -Denmark said on Monday it would spend 14.6 billion Danish crowns ($2.05 billion) boosting its military presence in the Arctic, following renewed interest by U.S. President ...

Jennifer Lagemann is a former family caregiver, as well as a professional caregiver and administrator at home care agencies. She works as a writer and researcher, helping care providers create ...

As of Tuesday, the "Denmarkification" petition – which calls for the country of Denmark to buy the state of California – has collected more than 200,000 signatures. The petition comes in ...

Commissions do not affect our editors' opinions or evaluations. Medicare can be a complicated subject—especially when you dive into all its variations. “A lot of people hear ‘Part A,’ ‘P ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators’ price negotiations with pharmaceutical manufacturers ...